The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study—a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
23 Apr 2023	Submitted	Original manuscript
27 May 2023	Reviewed	Reviewer Report - Kirsty Loudon
5 Jun 2023	Author responded	Author comments - Emmanuel Kofi Addo
Resubmission - Version 2
5 Jun 2023	Submitted	Manuscript version 2
Publishing
6 Jun 2023	Editorially accepted
19 Jun 2023	Article published	10.1186/s13063-023-07436-4

Back to article page